Replies to post #145 on Nuvectra Corp. (fka NVTRQ)

[joseytheoutlawwales]

Buying the dip.

Q losses due to expansion of markets, employee expansion, etc.

Still a growth story, and story remains intact.
FDA and CE mark catalysts upcoming.